Preparation and characterization of vinylimidazole-based polymer monolithic stationary phases for reversed-phase and hydrophilic interaction capillary liquid chromatography

Talanta
Shu-Ling Lin, Ming-Ren Fuh

Abstract

In this study, we applied 1-vinylimidazole (VIM) as the functional monomer to prepare a series of VIM-based monolithic stationary phases for both reversed-phase and hydrophilic interaction capillary liquid chromatography (LC) using various dimethacrylates (EDMA: ethylene dimethacrylate; HDDMA: 1,6-hexanediol dimethacrylate; DDDMA: 1,10-decanediol dimethacrylate) as cross-linkers. With a simple thermally initiated free-radical cross-linking polymerization process, VIM-based monolithic stationary phases have been successfully prepared. The porosity, permeability, and column efficiency of synthesized VIM-based monolithic stationary phases were characterized. With similar total porosity (85-90%), the VIM-HDDMA monoliths showed the lowest permeability among the three sets of VIM-based stationary phases. Various sets of non-polar (alkyl benzenes and polycyclic aromatic hydrocarbons) and polar analytes (phenol derivatives and amphenicol antibiotics) were applied as model compounds to further investigate the retention behavior of the VIM-based monolithic stationary phases for reversed-phase capillary LC analysis using selected VIM-based monolithic columns. While a mixture of organic acids was employed to perform HILIC analysis using th...Continue Reading

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.